Clinical Trial Update: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of paltusotine in patients with carcinoid syndrome completed with results posted, detailing safety, pharmacokinetics, and dose-response data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome
• Carcinoid Tumor

Drugs mentioned

• Paltusotine (paltusotine)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Carcinoid Syndrome, Carcinoid | Phase 2 | Status: COMPLETED | Results posted: 2025-10-31